hcpcs data

C9062

Injection, daratumumab 10 mg and hyaluronidase-fihj

Medicare: Special coverage instructions applyC seriesAdded October 01, 2020

What C9062 means

C9062 (Daratumumab hyaluronidase) belongs to the HCPCS Level II C series (Outpatient Prospective Payment System (OPPS)). Its Medicare coverage status is Special coverage instructions apply. Review the relevant Medicare manual or National Coverage Determination before billing.

Part B pricing: Statute.

J9144

CMS cross-references this code to J9144. Check that code if C9062isn't payable for your claim.

Code details

Short description
Daratumumab hyaluronidase
Coverage code
D = Special coverage instructions apply
Pricing indicator
53 = Statute
Multiple pricing indicator
A = Not applicable as HCPCS priced under one methodology
Type of service
9 = Other medical items or services F = Ambulatory surgical center (facility usage for surgical services)
Action code
N = No maintenance for this code
Action effective date
January 01, 2021
Code added date
October 01, 2020
Data year
2026

Questions about C9062

What is HCPCS code C9062?

HCPCS code C9062 is a Level II code in the C series (Outpatient Prospective Payment System (OPPS)). Its full description is: "Injection, daratumumab 10 mg and hyaluronidase-fihj"

Is C9062 a CPT code?

No. C9062 is a HCPCS Level II code maintained by CMS, not a CPT (Level I) code from the American Medical Association. People often search for it as a CPT code because both code sets are reported on the same claims.

Does Medicare cover HCPCS code C9062?

The Medicare coverage code for C9062 is "Special coverage instructions apply". Review the relevant Medicare manual or National Coverage Determination before billing.

When was HCPCS code C9062 added?

C9062 was added to the HCPCS code set on October 01, 2020. The most recent action on it (No maintenance for this code) took effect on January 01, 2021.

All C codes